WASHINGTON, DC, October 01, 2026 /24-7PressRelease/ — ADAP Advocacy today, as part of its 340B Project, released a new digital commercial about the 340B Drug Pricing Program. The commercial reinforces the central message of the policy paper the organization published earlier this year under the same name, “340B PROGRAM: The Glue That Should Hold Our Healthcare System Together.“
Few areas in the healthcare ecosystem aren’t, in one way or another, impacted by the 340B Program—including as the backbone for certain services and healthcare providers nationwide, such as HIV. For that reason, a healthcare program of this size, magnitude, and importance cannot be entrusted to good faith alone; rather, improved accountability and transparency guardrails are needed to ensure its success and ultimately its intended beneficiaries: patients.
Brandon M. Macsata, CEO of ADAP Advocacy, summarized: “The debate surrounding whether to reform the 340B Program has largely been settled, thanks to the growing chorus recognizing the program isn’t living up to the legislative intent. For patients, it is failing to deliver on its promise of expanding affordable healthcare, as shown by the growing medical debt crisis in this country, much of it owed to hospitals. Our new digital commercial moves the debate forward as Congress debates 340B legislation.”
The commercial will air across numerous digital and social platforms. The commercial continues ADAP Advocacy’s ‘340B Too Big To Fail‘ national advocacy campaign, highlighting hospitals’ declining charity, rising healthcare executive compensation, and exploding patient medical debt, among other issues.
The commercial is available online at https://tinyurl.com/bdea39d2.
To learn more about ADAP Advocacy, the 340B Drug Pricing Program, or the new 340B commercial, please email [email protected].
ADAP Advocacy’s mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community members, health care providers, government officials, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient education programs, and foster greater community collaboration.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer: The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at [email protected] with the specific URL of the content in question. We will review and address valid requests promptly.
